Abstract
Acute ischemic stroke is a leading cause of death and severe disability in industrialised countries and also in many developing countries. An excessive amount of free radicals is generated during cerebral ischemia, which significantly contributes to brain damage. Therefore, an increasing interest has been devoted to the potential benefits of antioxidant compounds in ischemic stroke patients. In this review, we examined the most relevant observational studies concerning the relationship between dietary antioxidants and ischemic stroke as well as clinical trials investigating the effects of single or multiple antioxidant supplementation in the prevention or treatment of acute ischemic stroke. Furthermore, we reviewed the most promising antioxidant compounds, i.e. dehydroascorbic acid, α-tocotrienol, γ- tocopherol, flavonoids, resveratrol and gingko biloba, tested in animal models of acute ischemic stroke. Finally, we carefully evaluated the reasons for the discrepancy between experimental and clinical studies, and provided recommendations to improve the translation of the results obtained in animal models to patients with acute ischemic stroke.
Keywords: Ginkgo Biloba, Vitamin C, Vitamin E Supplementation, Carotenoids, Flavonoids, Phytoestrogens
Current Medicinal Chemistry
Title: Dietary Antioxidants as Potential Pharmacological Agents for Ischemic Stroke
Volume: 15 Issue: 12
Author(s): A. Cherubini, C. Ruggiero, C. Morand, F. Lattanzio, G. Dell'Aquila, G. Zuliani, A. Di Iorio and C. Andres-Lacueva
Affiliation:
Keywords: Ginkgo Biloba, Vitamin C, Vitamin E Supplementation, Carotenoids, Flavonoids, Phytoestrogens
Abstract: Acute ischemic stroke is a leading cause of death and severe disability in industrialised countries and also in many developing countries. An excessive amount of free radicals is generated during cerebral ischemia, which significantly contributes to brain damage. Therefore, an increasing interest has been devoted to the potential benefits of antioxidant compounds in ischemic stroke patients. In this review, we examined the most relevant observational studies concerning the relationship between dietary antioxidants and ischemic stroke as well as clinical trials investigating the effects of single or multiple antioxidant supplementation in the prevention or treatment of acute ischemic stroke. Furthermore, we reviewed the most promising antioxidant compounds, i.e. dehydroascorbic acid, α-tocotrienol, γ- tocopherol, flavonoids, resveratrol and gingko biloba, tested in animal models of acute ischemic stroke. Finally, we carefully evaluated the reasons for the discrepancy between experimental and clinical studies, and provided recommendations to improve the translation of the results obtained in animal models to patients with acute ischemic stroke.
Export Options
About this article
Cite this article as:
Cherubini A., Ruggiero C., Morand C., Lattanzio F., Dell'Aquila G., Zuliani G., Iorio Di A. and Andres-Lacueva C., Dietary Antioxidants as Potential Pharmacological Agents for Ischemic Stroke, Current Medicinal Chemistry 2008; 15 (12) . https://dx.doi.org/10.2174/092986708784310431
DOI https://dx.doi.org/10.2174/092986708784310431 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of PPAR in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery The Effects of Antihypertensive Therapy on Haemostatic Parameters
Current Pharmaceutical Design Association of Admission Leukocyte Count with Clinical Outcomes in Acute Ischemic Stroke Patients Undergoing Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator
Current Neurovascular Research Improved Lipid Target Level Attainment in Patients with Peripheral Artery Disease
Current Vascular Pharmacology A1 Receptors Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry Reducing the Risk of Major Elective Non-cardiac Surgery: Is there a Role for Levosimendan in the Preoperative Optimization of Cardiac Function?
Current Drug Targets Preface (Hot Topic: Endocrine , Metabolic and Immunological Agents Executive Editors : Allan S . Wagman / Wayne L . Cody)
Current Pharmaceutical Design T Cell Homeostasis in Centenarians: From the Thymus to the Periphery
Current Pharmaceutical Design The Role of Co-Infections in Mother-to-Child Transmission of HIV
Current HIV Research The Use of SIFT-MS to Investigate Headspace Aldehydes as Markers of Lipid Peroxidation
Current Analytical Chemistry Perinatal and Neonatal Outcomes of Lithium-Treated and Untreated Bipolar Women During Pregnancy: A Review of Present Literature
Current Psychopharmacology Left Ventricular Hypertrophy: A Shift in Paradigm
Current Medicinal Chemistry Abdominal Aortic Calcification: Clinical Significance, Mechanisms and Therapies
Current Pharmaceutical Design The Role of Mitochondria in Piperine Mediated Cardioprotection in Isoproterenol Induced Myocardial Ischemia
Current Pharmaceutical Design Barker and Brenner: A Basis for Hypertension?
Current Hypertension Reviews Docosahexaenoic Acid and Membrane Lipid Domains
Current Organic Chemistry Gene Therapy for Osteoinduction
Current Gene Therapy Vitamin D, Sunlight and Cancer Connection
Anti-Cancer Agents in Medicinal Chemistry The Emerging Role of Arginase in Endothelial Dysfunction in Diabetes
Current Vascular Pharmacology Hypoxia in Pre-Eclampsia: Cause or Effect?
Current Women`s Health Reviews